A first-in-human study has shown that an autologous, multi-antigen T cell immunotherapy achieved durable disease control in ...
Eitan Medical Ltd. plans to launch its Avoset infusion system into the U.S. later this year, following the introduction of the multi-therapy ambulatory infusion system into the European market. The ...
MIDDLETON, Wis., Sept. 28, 2025 /PRNewswire/ -- Leo Cancer Care is using ASTRO 2025 to launch Grace™, the company's upright photon therapy system. Grace is named after American computer scientist and ...
The trial will enrol up to 70 patients with refractory glaucoma and has a 12-month primary effectiveness endpoint.
PhaseX: Patient tumor avatars for evaluating anticancer therapeutics. Mean OI and non-OI density per 1000 patient-days while on ICI alone vs ISTs.
Ion Beam Applications S.A. (IBA), a Belgium-based manufacturer of particle accelerator technology, said Thursday it has signed a contract with the Connecticut Proton Therapy Center to install a proton ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results